Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea FDA to weigh easing limits on unproven peptides Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, Orthopedic Use of BPC 157 Sports Med Review